MANAGEMENT OF ADVERSE REACTIONS TO TRIMETHOPRIM-SULFAMETHOXAZOLE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS

被引：64
|
作者：
JUNG, AC
PAAUW, DS
机构：
[1] Department of Medicine, University of Washington, Seattle, WA
[2] Department of Medicine, Div. of General Internal Medicine, University of Washington, Seattle
来源：
ARCHIVES OF INTERNAL MEDICINE | 1994年 / 154卷 / 21期
关键词：
D O I：
10.1001/archinte.154.21.2402
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Trimethoprim-sulfamethoxazole is an important medication for the treatment and prevention of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Use of this medication has been limited by the high frequency of adverse reactions that occur in patients with human immunodeficiency virus disease. This article reviews the incidence and spectrum of adverse reactions and options for continuing therapy with trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients who have adverse reactions.
引用
收藏
页码：2402 / 2406
页数：5
相关论文
共 50 条
12345